The Potential Use of Nebulized Hydroxychloroquine for the Treatment of COVID-19
Condition: 2019 Novel Coronavirus Interventions: Drug: HCQ01; Other: standard of care (SOC) for COVID-19 Sponsors: Ministry of Health Jordan; King Hussein Cancer Center; ACDIMA Biocenter; Amman Pharmaceutical Industries; Sana Pharmaceutical Industry Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2021 Category: Research Source Type: clinical trials